Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for posting.
This leads me to believe that infringement will be a win for Amarin due to it will have to be taken for the life of the patients. IMO
So if they lose that then the next step is obviousness. This is a little grey in my mind. It had to be obvious before 2016 that what? It lowers trigs only and if so would not the jelis study help confirm that?
Also can they win one side and enter the market or does it have to be both?
Thanks for answering in advance..
I’m an engineer not a lawyer or doc..
Question, how close was it to going to trial when Teva settled?
This makes me wonder also how much they are wanting price manipulation if they know it is a waist of time?
Thanks for the reply. I am with you on there odds are good now my next decision is whether to hedge or not. To me it seem to be a waist of time(until it is not).
Hd with all things considered in your opinion and if this does go to trial without settlement. What odds do you give generics of winning and getting the green light to sell generic V.
Thanks BB
is R IT going to be in the trial and if not when will we know? Thanks for the reply in advance..
Interesting to me where is the rest of the document? I never start a thought out with however... wonder what that refers to sounds like the contrast of this blurb..
I think everyone has many guesses on what will happen. Remember analysts say 3-5 billion peak sale based on current label no analyst has assumed what label expansion will be and given a fair price.
I read most of these post and I think everyone thinks 10b in peak sales is doable. So what the question to me is how fast can they achieve 10b in sales give sales force and supply issues? I have seen some guesses 2021-22-23. I’ll pick 22 with label expansion that totals me at 80b in 8 years and let’s say 2.5 in 20 and 5 in 21. Now 87.5. This is a fair possibility.
So with this knowledge and they don’t GIA what would BP pay? My answer is at least half. What company would not want to double there money in 10 years plus have more market control.
Just MO time will tell and I’ll be watching.
I hope ur right. I have been watching another stock admp clock is ticking 3 weeks past padufa date no word from FDA. My fear is that FDA drags there feet into January with amrn, but time will tell.
heck 1 million was volume AH. That told me this was going to keep beating us up. I will by more when it settle down. sold at 23 a small portion of shares, so i have some dry powder.
I don't see much action in the option market. This seems to be all retailers selling.
They are easily frightened but they will be back and in greater numbers..
name that movie quote just watched is with my 5 year old..
I agree but 7 pt, that is extreme.
Hard for me to believe 7 pt. I think they know something and want to sell puts or cover naked options. We will see and I’ll be holding long and strong.
Thanks for confirming that JL. It has caused me some worry. I did not think they would have anything to compete with,but just worried they try and compare to Vascepa. Sales pitch....
Don’t sell out yet anything below 100pps is to cheap. I think 50 Billion is a fare price. IMO
Congratulations all long. Been a long road lots of worry but now all that remains is how big...
Can’t agree more. I just wonder if FDA will drag there feet on padufa date and push it back for a full 12 months...
That depend on what your expectations are for me it is in line with my expectation.
Another weekend another conspiracy theory. I don’t believe the MO will be much more than a foot note. Why do a DDI when FDA has already approved >500 are we to think these patient don’t matter, but anyone with 135-500 do and constitute more research. I guess if they never apply for label expansion no need to do research this people don’t count. There is also a jelis study that has no mineral oil 19% improvement for cvd events. This will be about how broad the label will be IMO. GL and if you keep looking you’ll just drive yourself insane.
Was not Lipitor a preventative drug and how much did Pfizer pay......
If it does not meet the criteria for accelerated so be it. To get someone to guide you though a process does not mean special treatment. just successfully completion. So with that said nothing was denied.
This board has become paranoid people trying to read between the lines. No priority in Europe are you surprised. It does not meet there criteria..
maybe adcom is just that a committee meeting to judge and recommend label. For Pete’s sake it already is approved..
And all the medical journals and endorsements. Still let’s read into it so we are scared of or own shadow.
I think adcom will be positive, label will get expanded, patents will hold and eu will approve end of story. Between now and then you can watch for ufo’s I think that’s more likely then some of these other theories to happen. Gl
Completely agree from 18-19 we have doubled sales. With expanded label we should double again at least. IMO
And lets get real GS loaned out at 18 for a target of 17 -6% that would not be good business. This is so transparent.